ViiV’s Rukobia wins EU authorisation to treat multidrug-resistant HIV
Rukobia is a first-in-class HIV attachment inhibitor
Read More
Tag: Rukobia
FDA approves ViiV’s novel HIV treatment Rukobia
60% of heavily treatment-experienced patients achieved undetectable viral load after taking the drug
Read More
